Test codes: 4661, 4662, 4663, 7352, 30340, 36333, 36552, 36553, 36554, 91244

References

  1. Barbhaiya M, Zuily S, Naden R, et al. The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria. Arthritis Rheumatol. 2023;75(10):1687-1702. doi:10.1002/art.42624.
  2. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295-306. doi:10.1111/j.1538-7836.2006.01753.x
  3. Arslan E, Branch DW. Antiphospholipid syndrome: diagnosis and management in the obstetric patient. Best Pract Res Clin Obstet Gynaecol. 2020;64:31-40. doi:10.1016/j.bpobgyn.2019.10.001
  4. BioPlex 2200 system APLS IgG. Package insert. BioRad Laboratories Inc; February 2019.
  5. BioPlex 2200 system APLS IgA. Package insert. BioRad Laboratories Inc; February 2019.
  6. BioPlex 2200 system APLS IgM. Package insert. BioRad Laboratories Inc; February 2019.
  7. Galli M. Interpretation and recommended testing for antiphospholipid antibodies. Semin Thromb Hemost. 2012;38(04):348-352. doi:10.1055/s-0032-1304716
  8. Adcock DM, Gosselin R, Kitchen S, et al. The effect of dabigatran on select specialty coagulation assays. Am J Clin Pathol. 2013;139(1):102–109. doi:10.1309/AJCPY6G6ZITVKPVH
  9. Gosselin R, Grant RP, Adcock DM. Comparison of the effect of the anti-Xa direct oral anticoagulants apixaban, edoxaban, and rivaroxaban on coagulation assays. Int J Lab Hematol. 2016;38(5):505–513. doi:10.1111/ijlh.12528
  10. Devreese KMJ. Noncriteria antiphospholipid antibodies in antiphospholipid syndrome. Int J Lab Hematol. 2024;46(Suppl 1):34-42. doi:10.1111/ijlh.14268

 


This FAQ is provided for informational purposes only and is not intended as medical advice. Test selection and interpretation, diagnosis, and patient management decisions should be based on the physician’s education, clinical expertise, and assessment of the patient.

 

Document FAQS.109 Version: 4

Version 4: effective 10/03/2024 to present
Version 3: effective 06/12/2024 to 10/03/2024 
Version 2: effective 06/24/2021 to 06/12/2024
Version 1 effective 04/09/2016 to 06/24/2021
Version 0 effective 11/04/2013 to 04/08/2016